Two independent epigenetic biomarkers predict survival in neuroblastomaYania Yáñez, Victoria Castel, Enrique Vidal et al.|Clinical Epigenetics|2015Cited by 33
Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targetsEsther Coronado, Jaime Font de Mora, Yania Yáñez et al.|Molecular Oncology|2020Cited by 9